Adams Noah, Pearce Ruth, Veale Jaimie, Radix Asa, Castro Danielle, Sarkar Amrita, Thom Kai Cheng
Faculty of Health Professions, School of Social Work, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Sociology, University of Warwick, Coventry, United Kingdom.
Transgend Health. 2017 Oct 1;2(1):165-175. doi: 10.1089/trgh.2017.0012. eCollection 2017.
The purpose of this review is to create a set of provisional criteria for Institutional Review Boards (IRBs) to refer to when assessing the ethical orientation of transgender health research proposals. We began by searching for literature on this topic using databases and the reference lists of key articles, resulting in a preliminary set of criteria. We then collaborated to develop the following nine guidelines: (1) Whenever possible, research should be grounded, from inception to dissemination, in a meaningful collaboration with community stakeholders; (2) language and framing of transgender health research should be non-stigmatizing; (3) research should be disseminated back to the community; (4) the diversity of the transgender and gender diverse (TGGD) community should be accurately reflected and sensitively reflected; (5) informed consent must be meaningful, without coercion or undue influence; (6) the protection of participant confidentiality should be paramount; (7) alternative consent procedures should be considered for TGGD minors; (8) research should align with current professional standards that refute conversion, reorientation, or reparative therapy; and (9) IRBs should guard against the temptation to avoid, limit, or delay research on this subject.
本综述的目的是制定一套临时标准，供机构审查委员会（IRB）在评估跨性别健康研究提案的伦理取向时参考。我们首先利用数据库和关键文章的参考文献列表搜索关于该主题的文献，从而得出一套初步标准。然后我们共同制定了以下九条指导方针：（1）只要有可能，研究从构思到传播都应基于与社区利益相关者的有意义合作；（2）跨性别健康研究的语言和框架不应带有污名化色彩；（3）研究结果应反馈给社区；（4）应准确且敏感地反映跨性别和性别多样化（TGGD）群体的多样性；（5）知情同意必须是有意义的，不存在强迫或不当影响；（6）保护参与者的隐私应是首要任务；（7）对于TGGD未成年人应考虑采用替代同意程序；（8）研究应符合当前反对转化、重新定位或修复性治疗的专业标准；（9）IRB应防范避免、限制或拖延该主题研究的诱惑。
